Literature DB >> 1380753

[Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages].

G G Bogovazova, N N Voroshilova, V M Bondarenko, G A Gorbatkova, E V Afanas'eva, T B Kazakova, V D Smirnov, A G Mamleeva, Iu A Glukharev, E I Erastova.   

Abstract

The purified preparations of Klebsiella bacteriophages, viz. the monovalent preparation of K. pneumoniae bacteriophage and the polyvalent bacteriophage preparation for the treatment of infections caused by K. ozaenae, K. rhinoscleromatis scleromatis and K. pneumoniae sensu lato, have been obtained. The bacteriophage preparations have proved to be nontoxic and safe for laboratory animals after the intraperitoneal injection of these preparations followed by the pathomorphological study of the internal organs of the animals. The clinical study of the newly developed bacteriophage preparations in the course of the treatment of purulent inflammatory diseases in 109 patients has revealed that the preparations are not reactogenic and exhibit sufficient effectiveness in the therapy of ozena, rhinoscleroma and Klebsiella infections with different localization of the infectious process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380753

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  13 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples.

Authors:  S Kumari; K Harjai; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

Review 3.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

4.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

Review 5.  The factors affecting effectiveness of treatment in phages therapy.

Authors:  Mai Huong Ly-Chatain
Journal:  Front Microbiol       Date:  2014-02-18       Impact factor: 5.640

Review 6.  Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'.

Authors:  Sabah A A Jassim; Richard G Limoges
Journal:  World J Microbiol Biotechnol       Date:  2014-04-30       Impact factor: 3.312

Review 7.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

8.  Study on the Effect of Oral Administration of Bacteriophages in Charles Foster Rats With Special Reference to Immunological and Adverse Effects.

Authors:  Mayank Gangwar; Sonam Rastogi; Digvijay Singh; Alka Shukla; Neeraj Dhameja; Deepak Kumar; Rajesh Kumar; Gopal Nath
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

Review 9.  Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?

Authors:  Matthew J Cheesman; Aishwarya Ilanko; Baxter Blonk; Ian E Cock
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

10.  Characterizing Phage Genomes for Therapeutic Applications.

Authors:  Casandra W Philipson; Logan J Voegtly; Matthew R Lueder; Kyle A Long; Gregory K Rice; Kenneth G Frey; Biswajit Biswas; Regina Z Cer; Theron Hamilton; Kimberly A Bishop-Lilly
Journal:  Viruses       Date:  2018-04-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.